Skip to main content
SpringerLink
Log in

Drug-eluting stents are cost saving among patients with a high in-stent restenosis risk,

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Mahieu J, De Ridder A, De Graeve D, Vrints C, Bosmans J.Economic analysis of the use of drug-eluting stents from the perspective of Belgian health care. Acta Cardiologica 62: 355-365, No. 4, Aug 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Drug-eluting stents are cost saving among patients with a high in-stent restenosis risk,. Pharmacoecon. Outcomes News 538, 4 (2007). https://doi.org/10.2165/00151234-200705380-00010

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705380-00010

Keywords

Search

Navigation